Drug Action
Methylprednisolone exerts predominantly glucocorticoid effects with minimal mineralcorticoid effects.
PDF page 1239
Loading InternPractice…
Drug reference
Methylprednisolone exerts predominantly glucocorticoid effects with minimal mineralcorticoid effects.
PDF page 1239
DEPO-MEDRONE ® Local inflammation of joints and soft tissues ▶BY INTRA-ARTICULAR INJECTION ▶Adult: 4–80 mg, select dose according to size; where appropriate dose may be repeated at intervals of 7–35 days, for details consult product literature
PDF page 1239
→Appendix 1: corticosteroids
PDF page 1239
Angioedema. cataract. confusion. delusions. depressed mood. diarrhoea. dizziness. drug dependence. dyslipidaemia. embolism and thrombosis. epidural lipomatosis. gastrointestinal disorders. glucose tolerance impaired. hallucination. hepatitis. hiccups. hypopituitarism. increased insulin requirement. intracranial pressure increased. memory loss. metabolic acidosis. muscle weakness. myalgia. neuropathic arthropathy. peripheral oedema. psychiatric disorder. schizophrenia exacerbated. sterile abscess. suicidal ideation. vision loss. withdrawal syndrome
PDF page 1239
There can be variation in the licensing of different medicines containing the same drug. Suspension for injection CAUTIONARY AND ADVISORY LABELS 10 ▶Depo-Medrone (Pfizer Ltd) Methylprednisolone acetate 40 mg per 1 ml Depo-Medrone 40mg/1ml suspension for injection vials | 1 vial P £3.44 DT = £3.44 | 10 vial P £34.04 Depo-Medrone 80mg/2ml suspension for injection vials | 1 vial P £6.18 DT = £6.18 | 10 vial P £61.39 Depo-Medrone 120mg/3ml suspension for injection vials | 1 vial P £8.96 DT = £8.96 | 10 vial P £88.81
PDF page 1239
Patient counselling is advised for methylprednisolone tablets and injections (steroid card).
PDF page 1239
4–80 mg, select dose according to size; where
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1239